Janux Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$17.26

-0.21 (-1.20%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 22 85%

Hold 3 12%

Sell 1 4%

Price Target

Analyst Price Target +184.5% upside

Low Target $33.46

Average Target $49.10

High Target $61.24

Current Price $17.26

Current
$17.26

Target
$49.10

$33.46 $49.10 avg $61.24

Scenario Analysis

Bear Case

$33.46

93.9%

Low target

Base Case

$49.10

+184.5%

Avg target

Bull Case

$61.24

+254.8%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$35.34

-51.2% from high

52-Week Low

$12.12

+42.4% from low

Target vs 52W High

$49.10

+38.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%